Efficacy and Safety Evaluation of Sintilimab or Placebo in Combination With XELOX as First Line Treatment in Patients With Gastric Cancer
Clinical trial NCT03745170 · COMPLETED
Trial details
- NCT number
- NCT03745170
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-19
- Primary completion
- 2021-06-20
- Enrollment
- 650
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.